BaseHealth's Genophen Uses Genomic, Lifestyle, Clinical Data to Personalize Health Management Strategies | GenomeWeb

NEW YORK (GenomeWeb) – Newly renamed BaseHealth officially launched its first product for the life sciences market this week, a health management platform for doctors called Genophen that combines genomic, clinical, and lifestyle information to assess patients' risk of developing more than 40 complex diseases, thus allowing physicians to intervene early and recommend behavioral modification strategies to help their patients reduce risk and improve long-term health.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.